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Abstract
Painful peripheral neuropathy has been correlated with various voltage-gated sodium chan-
nel mutations in sensory neurons. Recently Nav1.9, a voltage-gated sodium channel sub-
type, has been established as a genetic influence for certain peripheral pain syndromes. In
this study, we performed a genetic study in six unrelated multigenerational Japanese fami-
lies with episodic pain syndrome. Affected participants (n = 23) were characterized by infan-
tile recurrent pain episodes with spontaneous mitigation around adolescence. This unique
phenotype was inherited in an autosomal-dominant mode. Linkage analysis was performed
for two families with 12 affected and nine unaffected members, and a single locus was iden-
tified on 3p22 (LOD score 4.32). Exome analysis (n = 14) was performed for affected and
unaffected members in these two families and an additional family. Two missense variants
were identified: R222H and R222S in SCN11A. Next, we generated a knock-in mouse
model harboring one of the mutations (R222S). Behavioral tests (Hargreaves test and cold
plate test) using R222S and wild-type C57BL/6 (WT) mice, young (8–9 weeks old; n = 10–
12 for each group) and mature (36–38 weeks old; n = 5–6 for each group), showed that
R222S mice were significantly (p < 0.05) more hypersensitive to hot and cold stimuli than
WTmice. Electrophysiological studies using dorsal root ganglion neurons from 8–9-week-
old mice showed no significant difference in resting membrane potential, but input imped-
ance and firing frequency of evoked action potentials were significantly increased in R222S
mice compared with WTmice. However, there was no significant difference among Nav1.9
(WT, R222S, and R222H)-overexpressing ND7/23 cell lines. These results suggest that our
novel mutation is a gain-of-function mutation that causes infantile familial episodic pain. The
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mouse model developed here will be useful for drug screening for familial episodic pain syn-
drome associated with SCN11Amutations.
Introduction
The recent identification of genetic variants causing pain-related disorders has created a new
window into the etiology of hereditary pain. Voltage-gated sodium ion channels have been
intensively studied, with a broad spectrum of new findings uncovered for peripheral neuropa-
thy. Among the nine subtypes (Nav1.1–Nav1.9) encoded by the genes SCN1A–SCN5A and
SCN8A–SCN11A, three subtypes (Nav1.7, Nav1.8, and Nav1.9) are strongly expressed in sen-
sory neurons, and have been associated with human pain disorders. Mutations in SCN9A cause
a spectrum of clinical phenotypes ranging from congenital insensitivity to pain [1], as well as
chronic pain syndromes such as paroxysmal extreme pain disorder [2,3], inherited erythrome-
lalgia [4,5], and small fiber neuropathy [6]. In contrast, Nav1.8 is associated with phenotypes
ranging from painful symptoms [7] to Brugada syndrome [8].
Nav1.9, which is encoded by SCN11A, is a tetrodotoxin (TTX)-resistant (TTXr) channel pri-
marily expressed in nociceptors. Nav1.9 channels exhibit hyperpolarized voltage-dependent
activation close to the resting membrane potential (RMP), with slow inactivation leading to a
persistent current [9]. Hence, Nav1.9 is thought to be an important regulator of membrane
excitability. Recently Nav1.9 was identified as the genetic background for some peripheral pain
syndromes. In a German family with an unusual syndrome involving loss of pain sensation, a
de novomissense SCN11Amutation (p.L811P; we have abbreviated the prefix “p” in this
paper) was found [10]. In another screening of SCN11A in 58 independent individuals with
early onset severe sensory loss, a Swedish male was identified as a patient with exactly with the
same heterozygous mutation (L811P), again occurring as a de novo event. This Nav1.9 variant
was examined electrophysiologically in Scn11a+/L799P knock-in mice (L799P being the mouse
ortholog), and exhibited excess sodium ion influx at rest with subsequent cell depolarization
[10].
In contrast, two large multigenerational Chinese families with autosomal-dominant epi-
sodic chronic pain and two types of gain-of-function SCN11Amutations (R225C and A808G)
were identified by genome-wide linkage analysis combined with whole-exome sequencing [11].
Overexpression of these mutants in mouse dorsal root ganglion (DRG) cells induced hyperex-
citability [11].
Recently, SCN9A, SCN10A, and SCN11A screening efforts in 393 patients with painful
peripheral neuropathy revealed causative SCN11Amutations (L1158P and I381T) [12]. Onset
of pain in these affected individuals was characteristically in adulthood, and therefore different
from the infantile period in the Chinese cases with SCN11Amutations. Further, the L1158P
and I381T mutations were often uniquely accompanied by burning sensations, and sometimes
autonomic dysfunction such as dry eyes, diarrhea, and urinary problems [12].
Collectively, Nav1.9 channelopathy is associated with diverse clinical phenotypes: painful
and painless peripheral neuropathy, as well as autonomic symptoms. Further studies are
needed to establish phenotype-genotype correlations in Nav1.9 channelopathy.
Here, we report two novel Nav1.9 variants (R222H and R222S) in patients of six unrelated
familial episodic pain syndrome. Furthermore, we generated a mouse model harboring one
of the mutations, R222S, and evaluated the model using a battery of behavioral tests. We
succeeded in partially recapitulating the clinical phenotype. Finally, we examined the
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electrophysiological mechanisms of the Nav1.9 variant in DRG neurons and Nav1.9-overex-
pressing ND7/23 cell lines, and found that the R222S mutation was associated with increased
firing probability in DRG neurons.
Materials and Methods
Ethical statements
A part of the human study was approved by the Institutional Review Board and Ethics Com-
mittee of Kyoto University School of Medicine (approval no. G501; approval date 2 Aug.
2012), and Japan and Akita University Graduate School of Medicine (approval no. 960; 26
Sep. 2012), Japan. Written informed consent was obtained from all subjects and the parents of
children and adolescents before participation.
Animal studies including animal care and all experimental procedures were in accordance
with the Animal Welfare Guidelines of Kyoto University or the in-house guidelines of the Insti-
tutional Animal Care and Use Committee of Daiichi Sankyo Co., Ltd. Animal experiment pro-
tocols were reviewed and approved by the Animal Care, Use and Ethics Committee at Kyoto
University (approval no. MedKyo15074; 27 Mar. 2015) and the Institutional Animal Care and
Use Committee of Daiichi Sankyo Co., Ltd. (approval no. A1500635, 26 Mar. 2015 [8–9-week-
old mice experiment]; A1502171, 16 Oct. 2015 [36–38-week-old mice experiment]).
Pedigrees and genomic DNA isolation
Six unrelated families were examined in this study (Fig 1A). Each family included a number of
affected and unaffected members. Peripheral blood was collected from 23 affected members
and 13 unaffected members from these families. Genomic DNA was extracted from whole
blood samples using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany).
Linkage analysis
Eight affected members (II-5, III-1, III-5, III-6, IV-1, IV-3, V-1, and V-3) and five unaffected
members (III-2, III-3, IV-2, IV-4, and IV-5) in Family 1 and four affected members (II-1, III-2,
III-3, and IV-3) and four unaffected members (II-2, III-1, IV-1, and IV-2) in Family 2 (Fig 1A)
were analyzed by genome-wide linkage analysis. Microsatellite polymorphisms (382 markers,
10 cM apart) covering 22 autosomes were genotyped using ABI Prism Linkage Mapping Set
(Version 2; Applied Biosystems, Foster City, CA, USA) as well as additional SNP markers.
Parametric linkage analysis was performed using 386 genetic markers by GeneHunter (Ver.
2.1_r6) [15] under an autosomal-dominant mode of inheritance. Disease allele frequency was
set at 10−5 and phenocopy frequency at 10−6. For individual alleles, population allele frequen-
cies were assigned equal proportions. Haplotypes in the families were estimated using Gene-
Hunter [15].
Whole-exome sequencing
Whole-exome sequencing was performed for 14 subjects: nine affected and five unaffected
members:, specifically, three affected members in Family 1 (III-1, V-1, and V-3), four affected
members (II-1, III-2, III-3, and IV-3) and four unaffected members (II-2, III-1, IV-1, and IV-
2) in Family 2, and two affected members (III-2 and IV-3) and one unaffected member (III-1)
in Family 3 (Fig 1A). Whole-exome sequencing was performed at Riken Genesis Co., Ltd
(Kanagawa, Japan). The target region (exonic regions and flanking intronic regions) was cap-
tured using the SureSelect Human All Exon V4+UTR Kit (Agilent Technologies, Santa Clara,
CA, USA), and sequencing performed using the Illumina HiSeq 2000 platform (Illumina Inc.,
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PLOS ONE | DOI:10.1371/journal.pone.0154827 May 25, 2016 3 / 23
Fig 1. Pedigrees of six Japanese familial episodic pain syndrome in Japanese families. (A) Some a)Family 2
and b)Family 3 members have been reported previously [13, 14]. Black and white symbols indicate affected and
unaffected individuals, respectively. Gray symbols indicate individuals with unknown phenotypic status. Squares and
circles indicate males and females, respectively. Slashes indicate deceased individuals. “P” indicates probands.
Blue arrows indicate exome sequenced individuals. * indicates linkage analysis performed individuals. The genotype
of SCN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222S (Family 3) for each individual is illustrated. (B)
Sequence chromatography of the identified SCN11Amutations.
doi:10.1371/journal.pone.0154827.g001
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San Diego, CA, USA). Sequence reads were mapped to the reference human genome (UCSC
Genome Browser hg19, http://hgdownload.cse.ucsc.edu/goldenPath/gh19/chromosomes/)
using Burrows-Wheeler Aligner software (Ver. 0.6.2) (http://bio-bwa.sourceforge.net/index.
shtml). Single-nucleotide variants and small insertion/deletions were detected using Genome
Analysis Toolkit software (Ver. 1.6–13) (https://www.broadinstitute.org/gatk/). A series of fil-
ters were used to identify candidate variants as follows: (1) non-synonymous variants (mis-
sense, nonsense, read through, splice site variants, and indels), (2) high read depth ( 8), (3)
not registered in dbSNP135 database (ftp://ftp.ncbi.nlm.nih.gov/snp/organisms/human_9606/
ASN1_flat), (4) less common (minor allele frequency (MAF)< 0.01) in Japanese patients from
the 1000 Genomes database (Oct 2011) (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/
20110521/), (5) heterozygote variant in all affected members and not present in unaffected
members of each family, (6) located in a linkage region, and (7) variants in the same gene
among the three families. For confirmation of the mutations, the SCN11A gene coding region
was sequenced by the Sanger method using primers described in S1 Table.
Restriction fragment length polymorphism method
Genotyping of R222H and R222S in the general population was performed by restriction frag-
ment length polymorphism (RFLP) using CviQI and DdeI. The primers and restriction
enzymes used are described in S2 Table.
Nav1.9 knock-in mouse
In mouse, R222S alteration is the allelic ortholog of the human R222S mutation, and was intro-
duced into the mouse Scn11a locus using the CRISPR/CAS9 system by TransGenic Inc.
(Kumamoto, Japan). Single guide RNAs (sgRNAs) targeting the region around the mouse
Scn11a R222 locus were designed using the Optimized CRISPR Design web tool (http://crispr.
mit.edu/) [16]. To avoid off-target effects, two sgRNAs were designed. Both oligonucleotide
DNAs coding sgRNAs (S3 Table) were synthesized, annealed, and cloned into the pX330-U6-
Chimeric_BB-CBh-hSpCas9 plasmid [17] obtained from Addgene (Addgene plasmid #
42230). Single-strand donor oligonucleotide DNA (donor oligoDNA) harboring a nucleotide
variant that introduces the R222S amino acid change was synthesized (Integrated DNA Tech-
nologies, Coralville, IA, USA) (S3 Table). Cas9+sgRNA vector and donor oligoDNA were
microinjected into fertilized C57BL/6 mouse eggs to generate Scn11a+/R222S mice. The nucleo-
tide change in genomic DNA that corresponds to Scn11a R222S was confirmed in offspring by
direct sequencing using the primers described in S3 Table. Further genotyping was performed
using TaqMan SNP genotyping assays (Applied Biosystems).
Behavioral experiments
Male knock-in (R222S mouse) and wild-type C57BL/6 mice (WT) were transferred from
Kyoto University to Daiichi Sankyo Co., Ltd. Mice were housed in an air-conditioned room
with controlled temperature (23 ± 2°C) and humidity (55 ± 10%) and a 12-h light/dark cycle
(light from 7:00 to 19:00). They were fed and given water ad libitum. In the following behav-
ioral experiments, the mice were used at 8–9 or 36–38 weeks old.
Irwin’s test: multiple neurobehavioral signs (a total of 45 observation items including aware-
ness, mood, motor activity, CNS excitation, posture, motor coordination, muscle tone, reflexes,
and autonomic neurological signs and miscellaneous symptoms) were observed according to
the method of Irwin [18].
Locomotor activity: locomotor activity was measured using SCANET MV-40 (MELQEST,
Toyama, Japan), a device that uses infrared sensors to detect movement of an animal placed
Familial Episodic Pain and Nav1.9 Mutations
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individually in a transparent plastic cage (20 cm × 20 cm × 20 cm). Once the animal was placed
into the cage, detection of movement was started. Total horizontal movement was recorded for
30 min.
Von Frey test: sensitivity to a mechanical stimulus was assessed using von Frey filaments
(Aesthesio1, DanMic Global, LLC, San Jose, CA, USA). Each animal was placed individually
into a transparent plastic cage (8 cm × 7 cm × 8 cm) with a wire-mesh floor to allow insertion
of the filament from below. The filament was placed against the plantar surface of the left hind-
paw and acclimatized for not less than 30 min before testing. A 50% threshold, which indicates
the filament force at which an animal reacts in 50% of presentations, was determined using a
previously reported method [19]. Eight filaments with approximately equal logarithmic incre-
mental forces (0.02, 0.04, 0.07, 0.16, 0.4, 0.6, 1.0, and 1.4 g) were used.
Hargreaves test: sensitivity to a thermal stimulus was assessed using the PAW THERMAL
STIMULATOR (UCSD, San Diego, CA, USA). Each animal was placed individually in a trans-
parent plastic chamber (8 cm × 8 cm × 18 cm) with a glass floor, and acclimatized for not less
than 30 min before testing. A radiant light heat source located under the floor was focused
onto the plantar surface of the left hindpaw, and paw withdrawal latencies recorded. Latencies
were measured in triplicate for the left hindpaw of each animal, and the mean used for analysis.
A 20 sec cut-off time was employed to avoid tissue damage.
Cold plate test: sensitivity to a cold stimulus was assessed using the MK-350HC Hot/Cold
Plate Analgesia Meter (Muromachi Kikai Co., Ltd., Tokyo, Japan). Each animal was placed
individually in a transparent plastic cylinder cage (8 cm φ × 20 cm) with a cold plate floor at
10°C. The total number of nociceptive behaviors (e.g., lifting and shaking of paws and jump-
ing) was counted for 3 min.
Nav1.9-overexpressing ND7/23 cells
Nav1.9-overexpressing ND7/23 cells, mouse neuroblastoma cells and rat DRG neurons hybrid
cell line, were produced using the PiggyBac transposon system, as previously reported [20].
Briefly, cDNA comprising human Nav1.9 (WT, R222H mutant, and R222S mutant) coding
region (NM_014139.2) fused with 3xFLAG at the C terminus was synthesized by DNA2.0 Inc.
(Menlo Park, CA, USA), and cloned into a transposon vector (pJ508) containing a blasticidin
resistance gene (DNA2.0 Inc.). Nav1.9-3xFLAG transposon vectors were then transfected into
ND7/23 cells using FuGene6 (Promega, Madison, WI, USA). Cells stably expressing Nav1.9-
3xFLAG were selected in 5 μg/ml blasticidin (Invitrogen, Carlsbad, CA, USA), isolated from
individual cell colonies using a cloning disk, and expanded. Nav1.9-3xFLAG expression was
confirmed by immunocytochemistry and real-time quantitative PCR.
Immunocytochemistry
Nav1.9-overexpressing ND7/23 cells cultured at 28°C for 24 h were fixed in methanol, permea-
bilized with acetone, and blocked in 3% BSA. The cells were then incubated with a mouse
monoclonal anti-FLAG antibody (M2 clone; Sigma-Aldrich, St. Louis, MO, USA), followed by
Alexa Fluor 594-conjugated anti-mouse IgG (Thermo Fisher Scientific, Waltham, MA, USA).
Fluorescent signals were examined using a TCS SP8 confocal laser microscope (Leica, Heidel-
berg, Germany).
Real-time quantitative PCR
cDNA was obtained from Nav1.9-overexpressing ND7/23 cells using the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Real-time quantitative PCR for human
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SCN11A cDNA was performed using the primers described in S4 Table. Target cDNA expres-
sion levels were normalized to the corresponding Ppia expression levels.
Isolation of DRG neurons
DRG neurons were isolated, as previously reported [21], from L4 to L6 sections of 6–8-week-
old WT and R222S mice. Briefly, mice were anesthetized using sevoflurane and then perfused
in artificial cerebrospinal fluid (aCSF; [in mM] 124 NaCl, 5 KCl, 1.2 KH2PO4, 1.3 MgSO4, 2.4
CaCl2, 10 glucose, and 24 NaHCO3). DRG neurons were extracted from the spinal cord and
isolated with collagenase XI (Sigma-Aldrich) in incubation medium containing Earle’s bal-
anced salt solution (Sigma-Aldrich), in a 25 min incubation at 37°C. After collagenase diges-
tion, DRG cells were dispersed using fire-polished Pasteur pipettes and centrifuged three
times. Isolated DRG neurons were resuspended in aCSF and plated onto non-coated 12 mm
φ coverslips.
Electrophysiology
Nav1.9-overexpressing ND7/23 cells. Nav1.9-overexpressing ND7/23 cells (WT and
mutant [R222H, R222S]) and control cells (ND7/23 cells without Nav1.9 transfection) were
inoculated onto 12 mm φ glass coverslips, and incubated at 28°C with 5% CO2 for 16–24 h
before patch clamp recording. Currents were recorded using an Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA, USA), low-pass filtered at 5 kHz, and digitized using a
Digidata 1440A (Axon Instruments, Union city, CA, USA). The pipette solution contained (in
mM): 10 NaF, 110 CsF, 20 CaCl2, 2 EGTA, and 10 HEPES (pH 7.3 with KOH). The bath solu-
tion contained (in mM): 130 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.4
with NaOH). To select cells with overexpressed sodium channels and block TTX-sensitive
(TTXs) channels, blasticidin (50 μg/ml) and TTX (3 μM;Wako Pure Chemical Industries,
Osaka, Japan) were added to the bath solution. Patch pipettes were fabricated from thin-walled
borosilicate glass capillaries (King Precision Glass, Inc., Claremont, CA, USA), and had a resis-
tance of ~3.5 MO [22]. Series resistance was monitored during the recording session, and data
were rejected if their value changed by> 20%. Leak currents were subtracted using electrical
subtraction protocols (p/4). Data were acquired by pCLAMP 10 (Axon Instruments). Voltage-
dependent currents were acquired after achieving more than 5 min of whole-cell recording
conditions. To record the current/voltage (I/V) relationship of TTXr, cells were held at −100
mV and step pulses applied from −120–30 mV for 100 ms in 10-mV increments. We did not
include data for WT, R222S and R222H with the peak currents more than −10 pA, which cor-
responds with the peak amplitude of the control cells (See results). Current traces were filtered
with a low-pass Bessel setting of 10 kHz. Activation curves were obtained above the step pulse
and fitted to the Boltzmann function in the form of G = Gmax /{1+exp[(V1/2 − V)/k]}, where
Gmax is the maximum conductance, V1/2 is the mid-point of the activation curve, and k is the
slope factor. All data were obtained at 28°C.
Isolated DRG neurons. Electrophysiological data from isolated DRG neurons were col-
lected from small diameter (< 25 μm) cells fromWT and knock-in mice. Data were obtained
at 23–25°C within 8 h after isolation using an EPC-9 amplifier (HEKA Elektronik, Lambrecht,
Germany). Patch pipettes were fabricated from thin-walled borosilicate glass capillaries
(GC150TF-10, Harvard Apparatus, MA, USA) and had a resistance of 4–6 MO [23, 24]. Patch
pipette tips were fire-polished before use. Electrode capacitance was compensated electrically,
and series resistance was< 13 MO. Data were collected in cells were which required smaller
current than -30pA to hold the membrane at -60 mV. A previous study found that mouse
DRG neurons initially up-regulate I(NaN) after cell rupture [25], therefore to avoid dispersion
Familial Episodic Pain and Nav1.9 Mutations
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of this effect on action potential (AP) firing, current-clamp recordings were obtained after
achieving more than 5 min of whole-cell recording conditions. The pipette solution contained
(in mM): 67 KCl, 65 K-gluconate, 1 MgCl2, 5 EGTA, 4 ATP-Mg, 1 GTP-Na2, and 10 HEPES
(pH 7.3 with KOH). The bath solution for isolated DRG neurons contained (in mM): 130
NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.4 with NaOH). TTX (1 μM)
was added to the bath solution to block TTXs sodium channels.
RMP was measured when the membrane potential was stabilized over 5 min after the
whole-cell recording configuration was achieved. RMP was measured immediately before cur-
rent injection in every trial. The following parameters of the first AP were measured: ampli-
tude, 50% AP width, and maximum rate of rise/fall of AP. To evaluate input impedance, the
voltage response amplitude was measured at a current injection of 10 pA. AP frequency was
calculated from the AP number during step current injections (500 ms) from 10 to 210 pA in
25 pA increments. The current injection was limited to 210 pA because firing was not observed
with currents larger than 210 pA owing to sodium channel inactivation. Cells that did not gen-
erate APs [26] or had only one AP in response to a 500-ms current stimulus in all step pulses
were excluded from analysis. All data were acquired using Patchmaster (HEKA Elektronik).
Electrophysiological data of isolated DRG neurons were analyzed using Igor Pro (WaveMetrics
Inc., Portland, OR, USA).
Statistical analysis
Behavioral test and electrophysiological data were presented as mean ± standard error of the
mean (S.E.M.). Statistical significance was determined by two-sided Student’s t-tests. All statis-
tical analyses were performed using SAS software (Version 9.4; SAS Institute, Cary, NC, USA).
Statistical significance was indicated by p< 0.05.
Results
Phenotypic characterization
The clinical features of the six pedigrees examined in this study (Fig 1A) are described below.
Family 1. The proband (V-1) is a 4-year-old girl born to nonconsanguineous parents after
an uneventful delivery. Recurrent, unexpected crying and unpleasantness were recognized dur-
ing her infancy. Around the age of 2 years, the mother noticed this was due to paroxysmal limb
pain. The patient grew up normally and developed without other problems. The pain was par-
tially relieved with oral acetaminophen, but was persistent, leading to referral to our hospital at
the age of 4 years.
The characteristics of her limb pain were that it began abruptly and continued for 15–30
min, but occasionally for half or even a whole day. Typically the pain was induced by fatigue or
weather changes, specifically atmospheric depression leading to cold weather, rain, and snow.
The paroxysmal pain episodes occurred approximately 10 and 20 days a month during sum-
mer and winter, respectively. The patient is afebrile during an episode and has a cold sensation
on the affected limb, being one or two elbows, wrists, knees, and ankles, without any other
symptoms e.g., redness, rashes, swelling, and joint destruction. Physical examination did not
reveal any abnormalities. Laboratory assessment did not show any suggestion of collagen dis-
eases, autoimmune diseases, or other disorders. Her laboratory data was normal, as follows:
peripheral blood count, coagulation system, erythrocyte sedimentation rate, C-reactive protein,
ferritin, serum amyloid A protein, soluble interleukin receptor 2, IgD, complement levels, anti-
nuclear and anti-cardiolipin antibodies, rheumatoid factor, anti-CCP antibody, serum lactate
and pyruvate levels, amino acid analysis, and leukocyte alpha-galactosidase activity.
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The father of the proband (IV-1), a 41-year-old man, showed similar symptoms during
childhood. However, his paroxysmal pain episodes gradually decreased from around the age of
15 years, and now occur only once or twice a year. He sometimes has a throbbing headache,
but has not yet been assessed in a hospital.
The other patients (IV-3, III-1, III-5, III-6, and II-5) all showed a similar clinical course.
Their paroxysmal pain episodes decreased during their adolescence. This family is originally
from Akita Prefecture.
Family 2. This family has previously been reported [13]. The proband (III-2), a 51-year-
old woman, had paroxysmal and cyclic limb pain in her childhood. Although her paroxysmal
pain episodes gradually decreased from around 15 years of age, intermittent episodes made her
visit a physician when she was 36 years old. She noticed her son had the same symptoms (IV-
3). The limb pain affected her quality of life; e.g., she could not attend elementary school. From
our investigation, we identified four males and three females in her family who all showed clin-
ical features similar to the proband’s. Their limb pain is almost identical to that of Family 1.
However, it lasts for a longer time in some individuals and repeats several times after an inter-
mittent period of a few hours, resulting in a series of pain. Their limb pain characteristically
precedes weather changes, in particular before low air pressure and bad weather; therefore,
they can anticipate impending bad weather. Indeed, “weather forecaster” has become their
nickname within the family. With regards age dependency, the paroxysmal pain episodes grad-
ually decreased from around 15 years of age in all affected individuals. They have frequently
used acetaminophen for pain relief. This family is originally from Chiba Prefecture.
Family 3. This family has previously been reported [14]. Briefly, eight males and five
females are affected with similar limb pain as in the other families. The proband (IV-3), a
3-year-old boy, started recurrent episodes of unexplained crying at 6 months of age, which was
recognized to be the result of limb pain. Besides the shared feature of limb pain, he occasionally
had migraine episodes. Paroxysmal limb pain and migraine have not occurred simultaneously.
This family is originally from Tottori Prefecture.
Families 4, 5, and 6. Four males and three females are recognized as affected with parox-
ysmal limb pain in Family 4. Ten males and 10 females are confirmed to have paroxysmal limb
pain in Family 5. Headache (not yet diagnosed as migraine) is another complaint in an individ-
ual of this family (V-2). Finally, six males and nine females had paroxysmal limb pain during
their infancy in Family 6. In these three families, age dependency was confirmed and the parox-
ysmal limb pain episodes decreased from around 15 years of age. These families are originally
from Akita Prefecture.
In summary, the affected joints in frequency order are: knees, ankles, wrists, and elbows.
Occasionally, the pain is localized to the forearms, brachium, palm, fingers, thigh, lower leg,
and acrotarsium. The pain usually occurs on one side of the extremities, but occasionally on
both sides. The pain typically lasts for 15–30 min and recurs several times a day. Moreover, it
tends to be more frequent and severe at night than daytime. The patients had recurrent epi-
sodes of night-time crying and sleep disturbances in childhood. These episodes were usually
present during the first few days of a series of painful days. The pain is often induced by fatigue
and a prelude of bad weather. The patients feel cold in the pain region and get relief by warm-
ing the lesion. The paroxysmal pain episodes appear to start during infancy and gradually
decrease from around 15 years of age. Finally, six affected individuals (family 2, IV-3; family 3,
III-3, IV-3, IV-4; family 6, V-3, VI-2) complained of anorexia and diarrhea following cessation
of a series of pain. These gastrointestinal manifestations are not observed in other mutation
carriers or unaffected members, being not segregated by Nav1.9 mutation.
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Clinical characterization
Almost all patients had a cold sensation in the affected limb. Therefore, we evaluated body sur-
face temperature by thermography in four patients during their pain attacks.
In a previous report [14], the surface of the affected limb had a lower temperature than the
contralateral side. In Family 3, it was higher in the affected forearm at the end of the pain
attack. We also examined body surface temperature in the other families (1, 2, 4, and 6), but no
significant difference was detected between the affected and contralateral limbs.
Nerve conduction velocity of the right median, right ulnar, right peroneal, and right tibial
nerves was individually examined in an individual from Family 1 (IV-1), and all showed nor-
mal findings. None of the affected subjects had shown a past electrocardiographic abnormality.
Genetic analysis
To identify the causative genes, we used a combined approach of linkage analysis and exome
sequencing. We first performed linkage analysis using Family 1 and 2, and identified a single
locus on chromosome 3p22 with a LOD score of 4.32 (Fig 2), suggesting that the causative gene
is located in this region.
We next performed exome analysis using three families (Fig 1A). Whole-exome sequencing
generated 9.3–14.7 billion bases from nine affected and five unaffected individuals. After map-
ping to the human reference genome (UCSC Genome Browserhg19), we obtained 6.8–12.0 Gb
of targeted exome sequence suitable for mapping, with a mean sequencing depth between 64-
and104-fold. The mean percentage of exomes covered a read depth of 8-fold, which
was> 94.7%. Filtering of variants was performed, with a focus on less common, deleterious
variants in coding sequence regions. We removed synonymous and low coverage (read
depth< 8) variants, and filtered against two reference databases (dbSNP135 and 1000
Genomes). Given that the families show an autosomal-dominant inheritance pattern, we
selected variants that were heterozygote in affected members and not present in unaffected
Fig 2. Genome-wide linkage analysis in two Japanese familial episodic pain syndrome families.Genome-wide linkage analysis was performed for
eight affected and five unaffected members in Family 1, and four affected and four unaffected members in Family 2. Parametric linkage analysis was
performed using 386 genetic markers (including 382 microsatellite genetic markers) that were 10 cM apart and covered 22 autosomes, as well as additional
SNPmarkers. GeneHunter software was used.
doi:10.1371/journal.pone.0154827.g002
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members. Consequently, 44, 10, and 91 variants were identified in Family 1, 2, and 3, respec-
tively (S5 Table). Further searching within the families for variants in the same gene on chro-
mosome 3p22 showed that all three families harbored a variant in the same codon of the
SCN11A gene: R222H (Family 1 and 2) and R222S (Family 3) (Fig 3). No other variant was
shared among the three families. We found no alterations in either SCN9A or SCN10A.
To determine segregation and confirm our exome analysis, direct sequencing of SCN11A
was performed in all six families. We found complete segregation with the episodic pain phe-
notype of R222H in Family 1, 2, 4, 5, and 6, and R222S in Family 3 (Fig 1).
To investigate the MAF, we genotyped SCN11A R222H and R222S in 105 in-house Japanese
controls by RFLP. Carriers of these two variants were not found in these controls.
Because five (Family 1, 2, 4, 5, and 6) out of six families harbor the same mutation i.e.,
R222H, we compared the haplotypes in these families using SNPs. Three different haplotypes
were identified, indicating that R222H is derived either from a founder mutation or a private
mutation (Fig 4).
Behavioral experiments using the R222Smouse
At 8–9 weeks, no abnormal signs were observed in general behavior or neurobehavioral func-
tion in R222S mice compared with WTmice (Irwin’s test). Two different age groups,
8–9-week-old and 36–38-week-old mice were used in the following behavioral experiments.
Locomotor activity was measured. No significant differences between R222S and WTmice
were found in either age group (S1 Fig). We compared sensitivity to mechanical, thermal, and
cold stimuli between R222S andWTmice. Sensitivity to a mechanical stimulus was determined
by measuring the 50% threshold in the von Frey test. In both age groups, the mean threshold
value in R222S mice (8–9 weeks old, 0.07 ± 0.01 g, n = 12; 36–38 weeks old, 0.25 ± 0.11 g,
n = 5) was lower than in WT mice (8–9 weeks old, 0.14 ± 0.03 g, n = 10; 36–38 weeks old,
0.52 ± 0.07 g, n = 6), but not statistically different (8–9 weeks old, p = 0.075; 36–38 weeks old,
p = 0.058) (Fig 5A and 5B). Sensitivity to a thermal stimulus was determined by measuring
paw withdrawal latency in the Hargreaves test. In both age groups, mean latency in R222S
mice (8–9 weeks old, 6.42 ± 0.57 s, n = 12; 36–38 weeks old, 9.96 ± 0.68 s, n = 5) was signifi-
cantly shorter than in WTmice (8–9 weeks old, 8.69 ± 0.80 s, n = 10; 36–38 weeks old,
14.71 ± 1.48 s, n = 6) (8–9 weeks old, p = 0.029; 36–38 weeks old, p = 0.024) (Fig 5C and 5D),
indicating that R222S mice show thermal hypersensitivity compared with WTmice. Sensitivity
to a cold stimulus was determined by measuring nociceptive behavior in the cold plate test. In
both age groups, the number of nociceptive behaviors in R222S mice (8–9 weeks old,
10.58 ± 1.45, n = 12; 36–38 weeks old, 5.20 ± 0.73, n = 5) was significantly higher than in WT
mice (8–9 weeks old, 5.10 ± 1.36, n = 10; 36–38 weeks old, 2.67 ± 0.21, n = 6) (8–9 weeks old,
p = 0.013; 36–38 weeks old, p = 0.0057) (Fig 5E and 5F), indicating that R222S mice show cold
hypersensitivity compared with WT mice.
Current-clamp characterization of DRG neurons in R222S andWTmice
To assess the effect of the R222S mutation on DRG neuronal excitability, we performed cur-
rent-clump recordings in small DRG neurons (< 25 μm) from R222S and WTmice (Fig 6).
We excluded the population of neurons that did not generate APs or had only one AP firing
from our analysis, since> 80% of DRG neurons that generated APs had repetitive APs.
There was no significant difference in RMP of DRG neurons betweenWT and R222S mice
(WT, −56.17 ± 9.64 mV, n = 3; R222S, −51.92 ± 5.74 mV, n = 4; p = 0.54). In contrast, the ampli-
tude of the first APs was significantly different betweenWT and R222S mice when measured
using a current injection of 210 pA (WT, 48.17 ± 26.76 mV, n = 5; R222S, 26.16 ± 12.51 mV,
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Fig 3. Exome analysis filtering process in the three Japanese familial episodic pain syndrome families. Exome
analysis was performed for three affected members in Family 1, four affected and four unaffected members in Family
2, and two affected and one unaffected member in Family 3. Exome data was processed through seven filtering steps:
(1) non-synonymous, (2) read depth 8, (3) not registered in dbSNP135, (4) MAF < 0.01 in Japanese patients from
1000 Genomes database, (5) heterozygote in affected members and not present in unaffected members, (6) located
on 3p22 linkage region, and (7) variants in the same gene among all three families. Numbers in boxes represent the
numbers of variants after each filtering step.
doi:10.1371/journal.pone.0154827.g003
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n = 5; p< 0.05), while 50% AP width was not significantly different (WT, 5.35 ± 2.24 ms, n = 5;
R222S, 7.41 ± 4.32 ms, n = 5; p = 0.38). The maximum rate of rise of AP (WT, 74.61 ± 31.78
mV/ms, n = 5; R222S, 34.69 ± 15.88 mV/ms, n = 5; p = 0.08) and fall of AP (WT, −39.26 ± 15.25
mV/ms, n = 5; R222S, −24.06 ± 11.29 mV/ms, n = 5; p = 0.15) was not significantly different
(Fig 6B and 6C), while input impedance in R222S mice were significantly higher than inWT
mice (WT, 262.0 ± 118.57 MO, n = 6; R222S, 677.43 ± 209.44 MO, n = 5; p< 0.05, Fig 6D).
These results suggest that DRG neurons of R222S mice can fire APs even with a low stimulus
input. Next, we examined firing frequency in WT and R222S mice by current injection. Repre-
sentative responses for DRG neurons from R222S andWTmice are shown (Fig 6E). In R222S
mice, the firing frequency increased with current injection, while firing frequency remained at a
low level inWTmice. Accordingly, firing frequency (calculated from the average number of
APs in 500 ms) was significantly higher (using a 185 pA input current) in R222S mice thanWT
mice (Fig 6E). These results suggest that excitability is higher in R222S mice thanWTmice.
Voltage-clamp characterization of Nav1.9-overexpressing ND7/23 cells
To determine the electrophysiological properties of Nav1.9 mutants (R222S and R222H), we
performed voltage-clamp recordings in Nav1.9 (WT, R222S, and R222H)-overexpressing
ND7/23 cells in the presence of 3 μMTTX (Fig 7A). Immunocytochemistry using anti-FLAG
tag confirmed Nav1.9 expression in the plasma membrane of Nav1.9-overexpressing ND7/23
cells (S2A Fig). The peak amplitude was larger in Nav1.9 (WT)-overexpressing ND7/23 cells
than control and Nav1.9 (R222S and R222H)-overexpressing ND7/23 cells (Fig 7B).
Fig 4. Three different haplotypes carrying R222H in five families.Haplotypes in Family 1, 2, 4, 5, and 6 are shown for five SCN11A variants (R222H,
P308L, C546C, V909I, and T1609I) and two microsatellite markers flanking SCN11A (D3S1277 [Position: 34,614,226 bp, NCBI build 38.2] and D3S1289
[Position: 54,445,451 bp, NCBI build 38.2]; determined in Family 1 and 2). Variant genotypes were determined by exome analysis or direct sequencing.
Microsatellite marker genotypes were determined using the ABI Prism Linkage Mapping Set. Three different haplotypes carrying R222H are represented in
orange, blue, and green boxes. Red characters show the minor R222H allele. Blue characters show genotypes not shared by the other families.
doi:10.1371/journal.pone.0154827.g004
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Fig 5. Behavioral phenotype comparison between R222S andWTmice. Sensitivity to a mechanical stimulus
(determined by measuring the 50% threshold in the von Frey test) in 8–9-week-old mice (A) and 36–38-week-old
mice (B); to a thermal stimulus (determined by measuring paw withdrawal latency in the Hargreaves test) in
8–9-week-old mice (C) and 36–38-week-old mice (D); to a cold stimulus (determined by measuring the number of
nociceptive behaviors in the cold plate test) in 8–9-week-old mice (E) and 36–38-week-old mice (F). Open and
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To determine the effect of gene transfer efficiency on current amplitude, we investigated the
relationship between current amplitude and expression level of the WT construct. As shown
(S2B Fig), current amplitudes were independent of expression levels.
The voltage-dependence of activation in Nav1.9-overexpressing ND7/23 cells was not sig-
nificantly different in Nav1.9 (WT, R222S, and R222H)-overexpressing cells (mV) (V1/2; WT:
−44.83 ± 2.44, n = 5, R222S: −39.5 ± 2.09, n = 5, R222H: −42.22 ± 2.91, n = 4, Fig 7C). However,
we were unable to analyze the inactivation curve because these currents were so small. These
results suggest that the characteristic electrophysiological properties of each mutation are not
different between Nav1.9 (WT, R222S, and R222H)-overexpressing ND7/23 cells.
Discussion
Here, we identified patients with typical childhood episodic pain symptoms in six unrelated
families from throughout Japan, and further, identified two missense mutations in SCN11A
(R222H and R222S) as the cause of the episodic pain. Given that these Nav1.9 variants are both
gain-of-function mutations, the phenotypes elicited by the mutations are divergent. There are
three subtypes of clinical manifestations i.e., loss of pain, painful small fiber neuropathy, and
familial episodic pain (Table 1) in affected individuals with Nav1.9 variants (described in previ-
ous reports [10–12, 27, 28]). While L811P is associated with loss-of-pain phenotypes [10],
other variants (e.g., G699R, L1158P, and I381T) are associated with small fiber neuropathy.
These variants cause painful small fiber neuropathy of late onset i.e., fifth or sixth decades, and
are complicated by skin discoloration and burning sensation, and autonomic dysfunction
including a sensation of dry eyes, diarrhea, urinary problems, palpitations, and orthostatic diz-
ziness [12, 27]. The third phenotype is familial episodic pain. The Nav1.9 mutations, R225C,
A808G, and V1184A have previously been reported in two Chinese families [11] and a family
of mixed European ancestry [28]. These affected cases and our affected subjects share similar
clinical characteristics (Table 1): early infantile onset of episodic pain and gradual amelioration
with growth, primary localization of pain in the lower limbs, induction by cold exposure or
weather changes, and alleviation of pain with anti-inflammatory medication. In some cases, it
may be misdiagnosed with other diseases such as growing pains, because of gradual ameliora-
tion in adolescence and no abnormal laboratory findings. Clinical severity and symptoms are
diverse, even in the same family, suggesting that the phenotype is modified by non-genetic fac-
tors. Further evaluation of the genotype-phenotype correlation is needed.
In our study, all patients had mutations at the arginine amino acid in position 222. Haplo-
type analysis revealed three different haplotypes carrying R222H, indicating that R222H is
derived not only from a founder mutation, but also as an independent mutation. Another
mutation, R222S, also occurred at the same position. Such a coincidental amino acid position
with a childhood-restricted episode strongly suggests that gain-of-function SCN11Amutations
and a painful childhood syndrome may have been overlooked in Japan because of self-limited
mitigation of pain episodes by growth. We are tempted to speculate that our cases represent
only the tip of the iceberg of such infantile patients.
Our behavioral experiments using knock-in mice successfully replicated the characteristic
features of painful behavior i.e., elevated cold sensitivity in patients. Furthermore, our in vivo
study confirmed that R222S is the gain-of-function mutation, with up-regulated excitability of
small DRG neurons observed in R222S knock-in mice by electrophysiological experiments.
closed columns showWT (8–9 weeks old, n = 10; 36–38 weeks old, n = 6) and R222Smice (8–9 weeks old,
n = 12; 36–38 weeks old, n = 5), respectively. Data are presented as mean and S.E.M. (*p < 0.05; two-sided
Student’s t test).
doi:10.1371/journal.pone.0154827.g005
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Fig 6. R222Smutation increases excitability in DRG neurons. (A) Small DRG neuron (< 25μm) responses to 500-ms
depolarizing current steps of 10, 110, and 210 pA in WT and R222Smice. The parameter of the first AP obtained during
current injections of 210 pA, showing calculated maximum rate of rise (B) and fall (C) of AP firing. Open and closed circles
represent WT (n = 4) and R222Smice (n = 5), respectively. (D) Input impedance was measured at an injection current of 10
pA. Open and closed columns represent WT (n = 6) and R222Smice (n = 5), respectively. (E) Comparison of repetitive
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Correspondingly, R222S mice demonstrate a chronic pain phenotype similar to that in
human. This chronic pain phenotype is explained by increased DRG neuronal excitability in
juvenile mice. It suggests that a mechanism of this pain is involved in higher electrical activity,
thereby promoting AP firing in DRG neurons. Interestingly, the symptoms in these mice did
not disappear after growth, which is different from the human case. A previous study has shown
that Nav1.9 glycosylation state is paralleled by developmental change. Moreover, enzymatic
desialidation of neonatal DRG cultures change TTXr properties in rat DRG cells [29]. However,
in the present study, the mouse R222S knock-in model did not replicate growth-dependent
action potentials betweenWT and R222Smice. Open and closed circles represent WT (n = 6) and R222Smice (n = 5),
respectively. The range of 500-ms-step current injections was 10–210 pA. Data are presented as mean ± S.E.M. (*p < 0.05;
two-sided Student’s t test).
doi:10.1371/journal.pone.0154827.g006
Fig 7. Characteristics of Nav1.9-overexpressing ND7/23 cells. (A) The typical traces of Na+ currents under 3 μMTTX treatment
among Nav1.9-overexpressing ND7/23 cells (Control, WT, R222S, and R222H) were selected at step pulses from −80–0 mV for 100
ms with 20-mV increments for clarity. Control indicates ND7/23 cells without Nav1.9 transfection. The data were obtained at 28°C.
Red-colored traces were obtained at −20 mV step pulse. (B) Current-voltage relationships for each Nav1.9-overexpressing ND7/23
cell (Control n = 5, WT n = 5, R222S n = 5, and R222H n = 4). Step pulses were applied from −120–30 mV for 100 ms in 10-mV
increments. (C) Comparison of activation of each Nav1.9-overexpressing ND7/23 cell. The Boltzmann fit correspond to V1/2 (WT:
−44.83 ± 2.44 mV, n = 5, R222S: −39.5 ± 2.09 mV, n = 5, R222H: −42.22 ± 2.91 mV, n = 4).
doi:10.1371/journal.pone.0154827.g007
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Table 1. Three subtypes of clinical manifestations.
Loss of pain
perception
Painful small fiber neuropathy Familial episodic pain
References Leipold et al [10]
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alleviation of pain sensitivity, suggesting that the rodent model does not represent age depen-
dency exactly as in human familial episodic pain syndrome. Thermal hypersensitivity in R222S
mice also differed from the finding that patients ameliorated their pain by warming the lesion.
Further investigation may reveal the correlation between cold/thermal sensitivity and Nav1.9
function.
Recent studies in humans have reported that 12 amino acid substitutions of Nav1.9 are rele-
vant to pain disorders, with seven of them associated with gain-of-function and painful/pain-
less phenotypes [10–12, 27, 28] (Table 1). Particularly, in a Chinese family with autosomal-
dominant episodic pain, a point mutation of SCN11A (R225C) alters the firing property despite
no significant difference in RMP and threshold [11]. This mutation is positioned at the S4 seg-
ment, which is the voltage censor domain. A previous study has shown that the S4 region in all
four domains of rat brain IIA and II sodium channels are involved in both activation and inac-
tivation gating [30, 31]. Therefore, the R225C mutation was expected to change voltage-depen-
dent gating of ion channels. However, Gmax and Imax does not change significantly [11]. In
mice, the R222S mutation is also in one of the multiple repeats of a motif consisting of a posi-
tively charged residue in the S4 segment, and did not change RMP by current-clamp recording.
We attempted to confirm the gating properties of the Nav1.9 mutations, R222S and R222H.
Activation curves from Nav1.9 mutation-overexpressing ND7/23 cells were not significantly
different with voltage steps. Our results are in accordance with observations on the R225C
mutation, which is located near this mutation [11]. However, inactivation gating was not con-
firmed in Nav1.9-overexpressing ND7/23 cells because these currents were so small. A lack of
inactivation data is one limitation of our current study. Thus, understanding of the detailed
mechanism underlying the gating property still requires further investigation.
Nav1.7, 1.8, and 1.9 are preferentially expressed in peripheral neurons and are implicated in
injury-induced neuronal hyperexcitability [11, 32, 33]. Recent studies have revealed an interac-
tion between a scaffolding protein and TTXs/TTXr neuronal channels. The binding domains
are weakly conserved and the core motif of the domain shared between potassium channels
[34, 35]. Particularly, Nav1.8 interacts constitutively with ankyrin G in skin nerve fibers. This
constitutive binding may contribute to pathological aspects of the illnesses caused by Nav1.8
ectopic expression [36, 37]. We demonstrated that the amplitude of the first AP was changed
by R222S mutation. The ratio of TTXs/TTXr currents will affect excitability [38]. Additionally,
Kv1 expression is reported in small DRG neurons [39]. Kv1 channels control the firing proper-
ties of neurons to generate a single spike at the onset of stimulus, and application of DTX, a
selective potassium channel blocker, blocks Kv1 channels and induces repetitive firing in the
auditory system [40, 41]. We found that the R222S mutation altered input resistance but did
not significantly affect the maximum rate of rise/fall of AP. These results are suggestive of a
mechanism whereby the R222S mutation may change the interplay with axonal channel com-
ponents in AP firing, including channel localization and distribution.
Impaired Nav1.9 function is correlated with three types of neuronal phenotypes: painless,
small fiber neuropathy, and familial episodic pain syndrome (Table 1). Onset of the latter two
phenotypes seems to be highly age dependent, but with the age of onset reversed: elderly for
small fiber neuropathy and infancy for familial episodic pain syndrome. Genotype and pheno-
type association has never been explored for Nav1.9 age dependency. A previous study has
shown that Dravet Syndrome, with progressive infantile onset epileptic encephalopathy caused
by loss-of-function mutations in SCN1A, is correlated with natural loss of Nav1.3 channel
expression in brain development, coupled with failure of increased functional Nav 1.1 channels
[42]. Expression of TTXs and TTXr is regulated by developmental changes of neurotropic fac-
tors and/or a shift in expression of specific neurotrophic receptors [43]. Thus, further studies
are warranted to elucidate the mechanisms of such an age dependency.
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Conclusions
In the present study, we identified SCN11A R222H and R222S in six unrelated Japanese fami-
lies with familial episodic pain syndrome. For R222S, we show the pathological role of this
mutation in familial episodic pain syndrome using a mouse knock-in model combined with
behavioral and electrophysiological examinations. The mouse model developed here will be
useful for drug screening for familial episodic pain syndrome associated with SCN11A.
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